Therabest
PrivateLast Round
Series C
Nov 19, 2021
Est. Valuation
$162.87M
Total Funding Raised
$22.05M
Company Overview
Therabest is a biotechnology company that develops next-generation immunotherapies using induced pluripotent stem cell (iPSC)-derived immune cells and nano-convergent drug delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therabest Comparables
Compare Therabest with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HebeCell | 89% | |
| Shoreline Biosciences | 84% | |
| Neukio Biotherapeutics | 84% |
Therabest Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 19, 2021 | ||||
| Series B | Jun 21, 2021 |
Therabest Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series C |
| Meritz Securities Co., Ltd. | Series C |
| DS Asset Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 51% MoM to 4.5K.
- Jan 20, 2026
Monthly visitors increased 171% MoM, reaching 3.8K.
Therabest Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Therabest's valuation, stock price, and market status.
Is Therabest a public or private company?
Therabest is a private company.
What is the current stock price of Therabest?
Therabest is a private company with no public stock price. No recent secondary market data is available.
How much is Therabest worth (valuation)?
Therabest's valuation is estimated at $162.9M based on funding round data.
Can I buy Therabest stock?
Therabest shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Therabest's last funding round?
Therabest's most recent funding round was Series C on November 19, 2021.
Who are the main investors in Therabest?
Key investors in Therabest include DA Value Investment, Meritz Securities Co., Ltd., DS Asset Management.
Will Therabest IPO soon?
No public IPO plans have been announced for Therabest.
How can I track Therabest secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therabest's secondary market activity and sign up for updates.